---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-065654"
form_type: "8-K"
ticker: "SERA"
cik: "0001534969"
company_name: "SERA PROGNOSTICS, INC."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T07:57:07.887021+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Sera Prognostics Q1 revenue $38k, net loss $8.2M; payor discussions advance

## Summary
- Revenue of $38k vs nil in prior year; net loss $8.2M vs $8.1M.
- Cash and securities $114.2M as of March 31, 2025.
- R&D expenses down 9% to $3.3M; SG&A up to $5.9M.
- PRIME study met primary success criteria; engaging payors and planning Medicaid pilots.
- Appointed Jeff Elliott to Board of Directors.

## SEC filing metadata
- accession: 0000950170-25-065654
- form_type: 8-K
- ticker: SERA
- cik: 0001534969
- company_name: SERA PROGNOSTICS, INC.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534969/000095017025065654/0000950170-25-065654-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534969/000095017025065654/sera-20250507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-065654
- JSON: https://secwatch.observer/filing/0000950170-25-065654.json
- Plain text: https://secwatch.observer/filing/0000950170-25-065654.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.